Back to Search Start Over

Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality

Authors :
René Andrié
D Chatterjee
Jonel Trebicka
Rajeshwar P. Mookerjee
Baravan Al-Kassou
Christian Jansen
Markus Linhart
Georg Nickenig
Helen E. Jones
Alessandra Pohlmann
Rohit Sawhney
Karen Louise Thomsen
Angela Gallego-Leon
Christian P. Strassburg
Jennifer Lehmann
Rajiv Jalan
Source :
Jansen, C, Chatterjee, D A, Thomsen, K L, Al-Kassou, B, Sawhney, R, Jones, H, Gallego-Leon, A, Lehmann, J, Pohlmann, A, Nickenig, G, Strassburg, C P, Andrie, R, Jalan, R, Linhart, M, Trebicka, J & Mookerjee, R P 2019, ' Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality ', Alimentary Pharmacology and Therapeutics, vol. 50, no. 5, pp. 568-579 . https://doi.org/10.1111/apt.15365
Publication Year :
2019
Publisher :
Wiley, 2019.

Abstract

Background Heart rate variability (HRV) is reduced in cirrhosis and in conditions of systemic inflammation. Whether HRV is associated with cirrhosis decompensation and development of acute-on-chronic liver failure (ACLF) is unknown. Aims To (a) validate wireless remote HRV monitoring in cirrhosis decompensation; (b) determine if severely reduced HRV is a surrogate for inflammation and progression of cirrhosis decompensation; (c) assess if measuring HRV determines prognosis in cirrhosis decompensation. Methods One hundred and eleven patients at risk of cirrhosis decompensation at two clinical sites were monitored for HRV. Standard deviation of all normal beat-beat intervals (SDNN) reflecting HRV was assessed using remote monitoring (Isansys Lifetouch) and/or Holter ECG recording. Clinical outcomes and major prognostic scores were recorded during 90-day follow-up. Results Reduced HRV denoted by lower baseline SDNN, correlated with severity of decompensation (median 14 (IQR 11-23) vs 33 (25-42); P

Details

ISSN :
02692813
Volume :
50
Database :
OpenAIRE
Journal :
Alimentary Pharmacology & Therapeutics
Accession number :
edsair.doi.dedup.....afc911ae7bba5bcc8938be3614c20ac2